PrecisionOS has received FDA approval to market its virtual reality surgical planning tool.

PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS™ a patient specific planning tool using Virtual Reality (VR). Surgeons can utilize an Oculus Quest 2 device to undertake preoperative planning with the patented software, which will be accessible in early 2022.

Read morePrecisionOS has received FDA approval to market its virtual reality surgical planning tool.

Digital health enters the metaverse

Metaverse technologies aren’t common in digital health just yet, but we’re seeing early signals of investment and innovation. 2021’s investors shelled out $198M in funding for U.S. digital health startups integrating VR or AR technologies across 11 deals, more than double the $93M raised across eight deals in 2020. However, 2021’s $198M investment was less … Read moreDigital health enters the metaverse